Literature DB >> 12232964

Heroin-assisted treatment as a response to the public health problem of opiate dependence.

Benedikt Fischer1, Jürgen Rehm, Maritt Kirst, Miguel Casas, Wayne Hall, Michael Krausz, Nicky Metrebian, Jean Reggers, Ambros Uchtenhagen, Wim van den Brink, Jan M van Ree.   

Abstract

Injection drug use (involving the injection of illicit opiates) poses serious public health problems in many countries. Research has indicated that injection drug users are at higher risk for morbidity in the form of HIV/AIDS and Hepatitis B and C, and drug-related mortality, as well as increased criminal activity. Methadone maintenance treatment is the most prominent form of pharmacotherapy treatment for illicit opiate dependence in several countries, and its application varies internationally with respect to treatment regulations and delivery modes. In order to effectively treat those patients who have previously been resistant to methadone maintenance treatment, several countries have been studying and/or considering heroin-assisted treatment as a complementary form of opiate pharmacotherapy treatment. This paper provides an overview of the prevalence of injection drug use and the opiate dependence problem internationally, the current opiate dependence treatment landscape in several countries, and the status of ongoing or planned heroin-assisted treatment trials in Australia, Canada and certain European countries.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12232964     DOI: 10.1093/eurpub/12.3.228

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  18 in total

1.  Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study).

Authors:  Benedikt Fischer; Jürgen Rehm; Suzanne Brissette; Serge Brochu; Julie Bruneau; Nady El-Guebaly; Lina Noël; Mark Tyndall; Cameron Wild; Phil Mun; Dolly Baliunas
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

Review 2.  Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood borne infections.

Authors:  Jesus Bucardo; Kimberly C Brouwer; Carlos Magis-Rodríguez; Rebeca Ramos; Miguel Fraga; Saida G Perez; Thomas L Patterson; Steffanie A Strathdee
Journal:  Drug Alcohol Depend       Date:  2005-04-01       Impact factor: 4.492

3.  The need to promote public health in the field of illicit drug use.

Authors:  Mark A Wainberg
Journal:  CMAJ       Date:  2006-11-21       Impact factor: 8.262

4.  Changes in illicit opioid use across Canada.

Authors:  Benedikt Fischer; Jürgen Rehm; Jayadeep Patra; Michelle Firestone Cruz
Journal:  CMAJ       Date:  2006-11-21       Impact factor: 8.262

5.  Hepatitis C, illicit drug use and public health: does Canada really have a viable plan?

Authors:  Benedikt Fischer; Kate Kalousek; Jürgen Rehm; Jeff Powis; Mel Krajden; Jens Reimer
Journal:  Can J Public Health       Date:  2006 Nov-Dec

Review 6.  Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics.

Authors:  Benedikt Fischer; Eugenia Oviedo-Joekes; Peter Blanken; Christian Haasen; Jürgen Rehm; Martin T Schechter; John Strang; Wim van den Brink
Journal:  J Urban Health       Date:  2007-07       Impact factor: 3.671

Review 7.  Prevention of HIV infection among injection drug users in resource-limited settings.

Authors:  David Vlahov; Angela M Robertson; Steffanie A Strathdee
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

8.  [The impact of opening a heroin-assisted treatment clinic on the surrounding neighborhood].

Authors:  Marc-André Ally; Serge Brochu; Etienne Blais
Journal:  Can J Public Health       Date:  2011 May-Jun

9.  Population pharmacokinetics of heroin and its major metabolites.

Authors:  Elisabeth J Rook; Alwin D R Huitema; Wim van den Brink; Jan M van Ree; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

10.  HIV infection among people who inject drugs: the challenge of racial/ethnic disparities.

Authors:  Don C Des Jarlais; Dennis McCarty; William A Vega; Heidi Bramson
Journal:  Am Psychol       Date:  2013 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.